Nextech Appoints Rusty Frantz as Chief Executive Officer
June 06, 2024 14:00 ET
|
Nextech Systems, Inc.
Nextech, a market leader of technology solutions for specialty physician practices, announced the appointment of Rusty Frantz as Chief Executive Officer.
Attovia Therapeutics Raises $105 Million Oversubscribed Series B Financing Led by Goldman Sachs Alternatives
May 09, 2024 07:30 ET
|
Attovia Therapeutics, Inc.
-- Proceeds support advancing Attovia’s lead programs through initial clinical readouts, expanding its pipeline, and ongoing development of the ATTOBODY™ platform -- Financing led by Goldman Sachs...
Nextech's New Revenue Cycle Management Services Increase Practice Collections an Average of 10%
May 08, 2024 09:00 ET
|
Nextech Systems, Inc.
Nextech has launched RCM professional billing services as part of its practice management software solution which can increase collections and reduce AR.
Context Therapeutics Announces $100 Million Private Placement
May 02, 2024 07:30 ET
|
Context Therapeutics Inc.
Financing includes new and existing leading healthcare investors Proceeds, along with existing cash and cash equivalents, are expected to extend cash runway into 2028 PHILADELPHIA, May 02, 2024 ...
New Nextech Med Spa for Wellness and Weight Loss Software Increases Average Patient Encounter Revenue by 70%
April 10, 2024 13:00 ET
|
Nextech Systems, Inc.
The new Nextech Med Spa for Wellness and Weight Loss empowers businesses with features like eRx and labs to easily expand their services and drive revenue.
Nextech Demos Patient Journey Innovations with Artificial Intelligence for Specialty Practices
March 22, 2024 13:15 ET
|
Nextech Systems, Inc.
Nextech today unveiled multiple transformative artificial intelligence solutions in its software during a demonstration at its annual user conference.
CHARM Therapeutics Announces Foundation of Scientific Advisory Board (SAB)
March 19, 2024 10:00 ET
|
Charm Therapeutics
PRESS RELEASE CHARM Therapeutics Announces Foundation of Scientific Advisory Board (SAB) LONDON – 19 March 2024 -- CHARM Therapeutics (“CHARM”, “The Company”), a 3D deep-learning research company...
Alumis Announces Upsized $259M Series C Financing to Advance Clinical-stage Pipeline of Oral Therapies Designed to Address Immune Dysfunction
March 06, 2024 08:00 ET
|
Alumis Inc
– Financing led by Foresite Capital, Samsara BioCapital and venBio Partners with participation from additional new and existing investors – – Proceeds will support ongoing comprehensive mid to...
Nextech to Unveil Patient Journey Innovations Driven by AI for Specialty Practices at 10th Annual EDGE User Conference
February 29, 2024 14:18 ET
|
Nextech Systems, Inc.
Nextech will announce its strategic vision for the future of technology-enabled patient journey innovations driven by AI at its EDGE user conference.
Nextech3D.ai Featured in Syndicated Broadcast Highlighting Launch of Next Era of GPT AI 3D Solutions
February 20, 2024 08:00 ET
|
Nextech3D.ai
LOS ANGELES, Feb. 20, 2024 (GLOBE NEWSWIRE) -- via IBN -- Nextech3D.ai (CSE: NTAR) (OTCQX: NEXCF) (FSE: 1SS), a Generative AI-Powered 3D model supplier for Amazon, P&G, Kohls, Miele and others...